Literature DB >> 29280054

Recent advances in the study of hepatitis B virus covalently closed circular DNA.

Mengying Ji1, Kanghong Hu2.   

Abstract

Chronic hepatitis B infection is caused by hepatitis B virus (HBV) and a total cure is yet to be achieved. The viral covalently closed circular DNA (cccDNA) is the key to establish a persistent infection within hepatocytes. Current antiviral strategies have no effect on the pre-existing cccDNA reservoir. Therefore, the study of the molecular mechanism of cccDNA formation is becoming a major focus of HBV research. This review summarizes the current advances in cccDNA molecular biology and the latest studies on the elimination or inactivation of cccDNA, including three major areas: (1) epigenetic regulation of cccDNA by HBV X protein, (2) immune-mediated degradation, and (3) genome-editing nucleases. All these aspects provide clues on how to finally attain a cure for chronic hepatitis B infection.

Entities:  

Keywords:  HBx; covalently closed circular DNA (cccDNA); genome-editing nucleases; hepatitis B virus (HBV); immunemediated

Mesh:

Substances:

Year:  2017        PMID: 29280054      PMCID: PMC6598884          DOI: 10.1007/s12250-017-4009-4

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  59 in total

1.  Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line.

Authors:  Darong Yang; Chaohui Zuo; Xiaohong Wang; Xianghe Meng; Binbin Xue; Nianli Liu; Rong Yu; Yuwen Qin; Yimin Gao; Qiuping Wang; Jun Hu; Ling Wang; Zebin Zhou; Bing Liu; Deming Tan; Yang Guan; Haizhen Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

Review 2.  Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure.

Authors:  Julie Lucifora; Ulrike Protzer
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

3.  Early inhibition of hepatocyte innate responses by hepatitis B virus.

Authors:  Souphalone Luangsay; Marion Gruffaz; Nathalie Isorce; Barbara Testoni; Maud Michelet; Suzanne Faure-Dupuy; Sarah Maadadi; Malika Ait-Goughoulte; Romain Parent; Michel Rivoire; Hassan Javanbakht; Julie Lucifora; David Durantel; Fabien Zoulim
Journal:  J Hepatol       Date:  2015-07-26       Impact factor: 25.083

Review 4.  HBV culture and infectious systems.

Authors:  C Nelson Hayes; Kazuaki Chayama
Journal:  Hepatol Int       Date:  2016-03-02       Impact factor: 6.047

Review 5.  Small Molecule Inhibitors of Hepatitis B Virus Nucleocapsid Assembly: A New Approach to Treat Chronic HBV Infection.

Authors:  Li Yang; Mengji Lu
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

6.  Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cells.

Authors:  Tomoo Ogi; Siripan Limsirichaikul; René M Overmeer; Marcel Volker; Katsuya Takenaka; Ross Cloney; Yuka Nakazawa; Atsuko Niimi; Yoshio Miki; Nicolaas G Jaspers; Leon H F Mullenders; Shunichi Yamashita; Maria I Fousteri; Alan R Lehmann
Journal:  Mol Cell       Date:  2010-03-12       Impact factor: 17.970

7.  Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA.

Authors:  Kouichi Kitamura; Zhe Wang; Sajeda Chowdhury; Miyuki Simadu; Miki Koura; Masamichi Muramatsu
Journal:  PLoS Pathog       Date:  2013-05-16       Impact factor: 6.823

8.  The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo.

Authors:  Su-Ru Lin; Hung-Chih Yang; Yi-Ting Kuo; Chun-Jen Liu; Ta-Yu Yang; Ku-Chun Sung; You-Yu Lin; Hurng-Yi Wang; Chih-Chiang Wang; Yueh-Chi Shen; Fang-Yi Wu; Jia-Horng Kao; Ding-Shinn Chen; Pei-Jer Chen
Journal:  Mol Ther Nucleic Acids       Date:  2014-08-19       Impact factor: 10.183

9.  DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.

Authors:  Yonghe Qi; Zhenchao Gao; Guangwei Xu; Bo Peng; Chenxuan Liu; Huan Yan; Qiyan Yao; Guoliang Sun; Yang Liu; Dingbin Tang; Zilin Song; Wenhui He; Yinyan Sun; Ju-Tao Guo; Wenhui Li
Journal:  PLoS Pathog       Date:  2016-10-26       Impact factor: 6.823

10.  IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.

Authors:  Gianna Aurora Palumbo; Cecilia Scisciani; Natalia Pediconi; Leonardo Lupacchini; Dulce Alfalate; Francesca Guerrieri; Ludovica Calvo; Debora Salerno; Silvia Di Cocco; Massimo Levrero; Laura Belloni
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

View more
  4 in total

Review 1.  HBV cccDNA and Its Potential as a Therapeutic Target.

Authors:  Anjing Zhu; Xinzhong Liao; Shuang Li; Hang Zhao; Limin Chen; Min Xu; Xiaoqiong Duan
Journal:  J Clin Transl Hepatol       Date:  2019-07-31

2.  LINC00844 promotes proliferation and migration of hepatocellular carcinoma by regulating NDRG1 expression.

Authors:  Wei Zhou; Kang Huang; Qiuyan Zhang; Shaojun Ye; Zibiao Zhong; Cheng Zeng; Guizhu Peng; Ling Li; Qifa Ye
Journal:  PeerJ       Date:  2020-01-28       Impact factor: 2.984

Review 3.  Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg).

Authors:  Satinder P Kaur; Arslan Talat; Hamidreza Karimi-Sari; Andrew Grees; Hao Wei Chen; Daryl T Y Lau; Andreea M Catana
Journal:  J Clin Med       Date:  2022-02-21       Impact factor: 4.241

Review 4.  HBV cccDNA-A Culprit and Stumbling Block for the Hepatitis B Virus Infection: Its Presence in Hepatocytes Perplexed the Possible Mission for a Functional Cure.

Authors:  Sajad Ahmad Bhat; Syed Naqui Kazim
Journal:  ACS Omega       Date:  2022-07-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.